Stay updated with breaking news from Destiny breast08. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Anastrozole or fulvestrant plus fam-trastuzumab deruxtecan-nxki demonstrated encouraging antitumor activity in patients with chemotherapy-naïve, HER2-low hormone receptor–positive metastatic breast cancer. ....